These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 7712482

  • 1. Suppression of the proliferation of Ras-transformed cells by fluoromevalonate, an inhibitor of mevalonate metabolism.
    Cuthbert JA, Lipsky PE.
    Cancer Res; 1995 Apr 15; 55(8):1732-40. PubMed ID: 7712482
    [Abstract] [Full Text] [Related]

  • 2. Regulation of proliferation and Ras localization in transformed cells by products of mevalonate metabolism.
    Cuthbert JA, Lipsky PE.
    Cancer Res; 1997 Aug 15; 57(16):3498-505. PubMed ID: 9270019
    [Abstract] [Full Text] [Related]

  • 3. Negative regulation of cell proliferation by mevalonate or one of the mevalonate phosphates.
    Cuthbert JA, Lipsky PE.
    J Biol Chem; 1991 Sep 25; 266(27):17966-71. PubMed ID: 1917936
    [Abstract] [Full Text] [Related]

  • 4. Inhibition by 6-fluoromevalonate demonstrates that mevalonate or one of the mevalonate phosphates is necessary for lymphocyte proliferation.
    Cuthbert JA, Lipsky PE.
    J Biol Chem; 1990 Oct 25; 265(30):18568-75. PubMed ID: 2211719
    [Abstract] [Full Text] [Related]

  • 5. Lovastatin inhibits proliferation of rat mesangial cells.
    O'Donnell MP, Kasiske BL, Kim Y, Atluru D, Keane WF.
    J Clin Invest; 1993 Jan 25; 91(1):83-7. PubMed ID: 8423236
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of cell growth by lovastatin is independent of ras function.
    DeClue JE, Vass WC, Papageorge AG, Lowy DR, Willumsen BM.
    Cancer Res; 1991 Jan 15; 51(2):712-7. PubMed ID: 1985788
    [Abstract] [Full Text] [Related]

  • 7. Proliferative effect of mevalonate metabolites other than isoprenoids on cultured vascular smooth muscle cells.
    Sawamura M, Li N, Nara Y, Yamori Y.
    Clin Exp Pharmacol Physiol; 1993 Jan 15; 20(7-8):509-14. PubMed ID: 8403532
    [Abstract] [Full Text] [Related]

  • 8. Pharmacological control of the mevalonate pathway: effect on arterial smooth muscle cell proliferation.
    Raiteri M, Arnaboldi L, McGeady P, Gelb MH, Verri D, Tagliabue C, Quarato P, Ferraboschi P, Santaniello E, Paoletti R, Fumagalli R, Corsini A.
    J Pharmacol Exp Ther; 1997 Jun 15; 281(3):1144-53. PubMed ID: 9190847
    [Abstract] [Full Text] [Related]

  • 9. The mevalonate pathway: importance in mesangial cell biology and glomerular disease.
    O'Donnell MP, Kasiske BL, Kim Y, Atluru D, Keane WF.
    Miner Electrolyte Metab; 1993 Jun 15; 19(3):173-9. PubMed ID: 8232104
    [Abstract] [Full Text] [Related]

  • 10. Effects of mevinolin and mevalonate on cell growth in several transformed cell lines.
    Fairbanks KP, Barbu VD, Witte LD, Weinstein IB, Goodman DS.
    J Cell Physiol; 1986 May 15; 127(2):216-22. PubMed ID: 3634776
    [Abstract] [Full Text] [Related]

  • 11. Effect of lovastatin and fluoromevalonate on phosphatidylinositol 3-kinase activity stimulated with PDGF.
    Iwama A, Sawamura M, Nara Y, Yamori Y.
    Clin Exp Pharmacol Physiol Suppl; 1995 Dec 15; 22(1):S318-20. PubMed ID: 9072409
    [Abstract] [Full Text] [Related]

  • 12. High glucose induced endothelial cell growth inhibition is associated with an increase in TGFbeta1 secretion and inhibition of Ras prenylation via suppression of the mevalonate pathway.
    Mather A, Chen XM, McGinn S, Field MJ, Sumual S, Mangiafico S, Zhang Y, Kelly DJ, Pollock CA.
    Int J Biochem Cell Biol; 2009 Mar 15; 41(3):561-9. PubMed ID: 18692592
    [Abstract] [Full Text] [Related]

  • 13. Isoprenoid regulation of cell growth: identification of mevalonate-labelled compounds inducing DNA synthesis in human breast cancer cells depleted of serum and mevalonate.
    Wejde J, Carlberg M, Hjertman M, Larsson O.
    J Cell Physiol; 1993 Jun 15; 155(3):539-48. PubMed ID: 8491791
    [Abstract] [Full Text] [Related]

  • 14. Restored expression of transforming growth factor beta type II receptor in k-ras-transformed thyroid cells, TGF beta-resistant, reverts their malignant phenotype.
    Coppa A, Mincione G, Lazzereschi D, Ranieri A, Turco A, Lucignano B, Scarpa S, Ragano-Caracciolo M, Colletta G.
    J Cell Physiol; 1997 Aug 15; 172(2):200-8. PubMed ID: 9258341
    [Abstract] [Full Text] [Related]

  • 15. Infection with a Kirsten-retrovirus can induce a multiplicity of tumorigenic phenotypes in the interleukin-3-dependent FDC-P1 cells.
    Duménil D, Neel H, Lacout C, Dautry F.
    Exp Hematol; 1994 Feb 15; 22(2):178-85. PubMed ID: 8299738
    [Abstract] [Full Text] [Related]

  • 16. Induced p21WAF1 expression acts to reverse myc myelomonocytic cell transformation.
    Dolnikov A, Millington M, Sun LQ, Symonds G.
    Cancer Gene Ther; 2000 Nov 15; 7(11):1491-503. PubMed ID: 11129291
    [Abstract] [Full Text] [Related]

  • 17. Isoprenylated proteins in cultured cells: subcellular distribution and changes related to altered morphology and growth arrest induced by mevalonate deprivation.
    Maltese WA, Sheridan KM.
    J Cell Physiol; 1987 Dec 15; 133(3):471-81. PubMed ID: 3693410
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of Ras farnesylation by lovastatin leads to downregulation of proliferation and migration in primary cultured human glioblastoma cells.
    Bouterfa HL, Sattelmeyer V, Czub S, Vordermark D, Roosen K, Tonn JC.
    Anticancer Res; 2000 Dec 15; 20(4):2761-71. PubMed ID: 10953355
    [Abstract] [Full Text] [Related]

  • 19. The cytokine receptor repertoire specifies autocrine growth factor production in factor-dependent cells.
    Rasko JE, Metcalf D, Gough NM, Begley CG.
    Exp Hematol; 1995 May 15; 23(5):453-60. PubMed ID: 7720817
    [Abstract] [Full Text] [Related]

  • 20. Effect of geraniol on fatty-acid and mevalonate metabolism in the human hepatoma cell line Hep G2.
    Polo MP, de Bravo MG.
    Biochem Cell Biol; 2006 Feb 15; 84(1):102-11. PubMed ID: 16462894
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.